State Healthcare Institution "Regional Clinical Oncological Dispensary" - Academic Profile

Publications

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang , Eric Van Cutsem , A. Feyereislova +13 more

2010 The Lancet 7049 citations

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer , B. Yа. Alekseev , Sun Young Rha +35 more

Lenvatinib plus pembrolizumab was associated with significantly longer progression-free survival and overall survival than sunitinib. (Funded by Eisai and Merck Sharp and Dohme;...

2021 New England Journal of Medicine 1597 citations

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Thomas Powles , Se Hoon Park , Éric Voog +24 more

Maintenance avelumab plus best supportive care significantly prolonged overall survival, as compared with best supportive care alone, among patients with urothelial cancer who h...

2020 New England Journal of Medicine 1374 citations

Affiliated Researchers

Institution Info

Type: government
Country: RU
Publications: 3
Citations: 10,020

External Links

Identifiers

ROR: https://ror.org/05j351806